PRAX Praxis Precision Medicines Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PRAX

Price (delayed)

$54.67

Market cap

$723.74M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$18.69

Enterprise value

$644.94M

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights ...

Highlights
PRAX's EPS has surged by 73% year-on-year and by 44% since the previous quarter
The net income has grown by 42% YoY and by 10% from the previous quarter
The quick ratio has soared by 76% year-on-year but it has declined by 14% since the previous quarter
PRAX's equity is down by 20% from the previous quarter and by 8% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://praxismedicines.com
Peers: OMER OMGA

Key stats

What are the main financial stats of PRAX
Market
Shares outstanding
13.24M
Market cap
$723.74M
Enterprise value
$644.94M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.72
Price to sales (P/S)
147.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
263.56
Earnings
Revenue
$2.45M
EBIT
-$123.28M
EBITDA
-$122.01M
Free cash flow
-$111.19M
Per share
EPS
-$18.69
Free cash flow per share
-$16.86
Book value per share
$8.13
Revenue per share
$0.37
TBVPS
$13.34
Balance sheet
Total assets
$87.95M
Total liabilities
$18.28M
Debt
$2.5M
Equity
$69.67M
Working capital
$69.13M
Liquidity
Debt to equity
0.04
Current ratio
5.39
Quick ratio
5.16
Net debt/EBITDA
0.65
Margins
EBITDA margin
-4,986%
Gross margin
100%
Net margin
-5,037.9%
Operating margin
-5,164.4%
Efficiency
Return on assets
-115.6%
Return on equity
-151%
Return on invested capital
N/A
Return on capital employed
-170.7%
Return on sales
-5,037.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PRAX stock price

How has the Praxis Precision Medicines stock price performed over time
Intraday
0.94%
1 week
-0.24%
1 month
3.15%
1 year
250.45%
YTD
145.38%
QTD
-10.41%

Financial performance

How have Praxis Precision Medicines's revenue and profit performed over time
Revenue
$2.45M
Gross profit
$2.45M
Operating income
-$126.37M
Net income
-$123.28M
Gross margin
100%
Net margin
-5,037.9%
The net income has grown by 42% YoY and by 10% from the previous quarter
The operating income is up by 41% year-on-year and by 10% since the previous quarter
The net margin has increased by 29% since the previous quarter
PRAX's operating margin is up by 29% since the previous quarter

Growth

What is Praxis Precision Medicines's growth rate over time

Valuation

What is Praxis Precision Medicines stock price valuation
P/E
N/A
P/B
6.72
P/S
147.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
263.56
PRAX's EPS has surged by 73% year-on-year and by 44% since the previous quarter
PRAX's equity is down by 20% from the previous quarter and by 8% YoY
The price to sales (P/S) is 96% more than the last 4 quarters average of 74.4
The revenue has increased by 27% since the previous quarter

Efficiency

How efficient is Praxis Precision Medicines business performance
PRAX's return on sales is up by 29% since the previous quarter
Praxis Precision Medicines's ROE has increased by 10% YoY and by 9% from the previous quarter
Praxis Precision Medicines's ROA has increased by 9% YoY and by 4.7% from the previous quarter

Dividends

What is PRAX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PRAX.

Financial health

How did Praxis Precision Medicines financials performed over time
The quick ratio has soared by 76% year-on-year but it has declined by 14% since the previous quarter
PRAX's current ratio has surged by 67% year-on-year but it is down by 12% since the previous quarter
The debt is 96% smaller than the equity
The debt to equity is up by 33% since the previous quarter but it is down by 20% year-on-year
The debt has declined by 29% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.